Andriy Luzhetskyy

Prof. Dr. Andriy Luzhetskyy is a faculty member at Saarland University, holding the Professorship for Pharmaceutical Biotechnology within the Department of Pharmaceutical Science in the Faculty of Natural Sciences and Technology. His research group focuses on advancing biotechnological methods for drug discovery and development, particularly through the genetic manipulation of microorganisms.

His research interests lie at the intersection of molecular biology and pharmaceutical sciences, with a strong emphasis on Pharmaceutical Biotechnology, Natural Product Biosynthesis, and Synthetic Biology. His work primarily involves the genetic engineering of actinomycetes—bacteria known for producing clinically important antibiotics—enabling the design of novel bioactive compounds. This research has significant implications for antibiotic discovery and the development of new therapeutic agents.

The trends in his research, though not detailed in specific publications here, center on microbial engineering, biosynthetic pathway manipulation, and the exploitation of bacterial genomes for pharmaceutical innovation. These efforts align with global needs for next-generation antimicrobials and sustainable drug production platforms.

• No scientific awards were mentioned in the provided text.

There is no information available regarding student advising, research grants, or specific funding projects. However, as a professor leading a research group, it is likely that he supervises PhD and Master’s students and participates in national or international research collaborations and grant initiatives.

The research is conducted through his working group in the Pharmaceutical Biotechnology unit at Saarland University, located on Campus C2.3 in Saarbrücken. The team operates within a modern academic research environment focused on interdisciplinary pharmaceutical sciences and biotechnological innovation.